Kailera Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Kailera Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kailera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kailera Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kailera Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $21M | 973k | 22.03 |